Comparison

MD2-TLR4-IN-1 European Partner

Manufacturer Selleckchem
Category
Type Inhibitors
Specific against other
Amount 25 mg
Item no. S0139-25
Targets CD284
CASRN 2249801-12-3
eClass 6.1 30220300
eClass 9.0 32160605
Available
Description
MD2-TLR4-IN-1 (compound 22m) is a potent inhibitor of myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4). MD2-TLR4-IN-1 (compound 22m) inhibits lipopolysaccharide (LPS)-induced expression of tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) in macrophages with IC50 of 0.89 uM and 0.53 uM, respectively.
Pathway
Immunology & Inflammation
Small Target
TLR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Delivery expected until 5/16/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close